Results per Page:
Driver’s ed: watching HSV co-infection and recombination in vivo
From the Jerome Lab, Vaccine & Infectious Disease Division
Anti-(idio)typical: a new immunogen to vaccinate against RSV
From the McGuire Lab, Vaccine & Infectious Disease Division
Engineered HSV can trigger genetic chain reaction, rejigger HSV genes during co-infection
Proof-of-concept work raises hope that ‘gene drive’ could one day form basis of curative gene therapy for herpes
Repping Epstein-Barr virus: RNA vaccine protects against cancer in mice
From the McGuire lab, Vaccine and Infectious Disease Division
Herpes cure with gene editing makes progress in laboratory studies
Fred Hutch virologists eliminated at least 90% of HSV-1 in preclinical models of oral and genital herpes and reduced viral shedding in a study published in Nature Communications
COVID-19 prior to cellular therapy is likely not a cause for alarm.
From the Hill Group, Clinical Research Division and Vaccine and Infectious Disease Division
A shot for every limb: how splitting up the HIV vaccine may increase immunogenicity
HIV Vaccine Trials Network (HVTN)
A tale of two T cells in Merkel Cell Carcinoma
From the Newell Lab, Vaccines and Infectious Disease Division
Hard to swallow? RORγt expression in Tregs may not regulate oral tolerance, as previously hypothesized.
From the Kublin Lab, Vaccine and Infectious Disease Division
Do viruses have heads, shoulders, knees, and toes?
From the Stamatatos, Pancera and McGuire labs, Vaccine and Infectious Disease Division
Coronavirus evolution resembles an intersecting network of branches
From the Bedford lab, Vaccine and Infectious Disease Division
Antivirals have untapped potential in reducing SARS-CoV-2 related deaths
From the Brown and Janes labs, Public Health Sciences and Vaccine and Infectious Disease Divisions
Discovering potential emerging SARS-CoV-2 variants
From the Zhao, Gilbert, Geraghty and Jerome labs, a collaboration between Public Health Sciences, Vaccine and Infectious Disease, and the Clinical Research Divisions
Naïve and memory T cells elicit a convergent response to CMV
From the Boeckh, Bradley, and Prlic Labs, a collaboration between the Vaccine and Infectious Disease, Clinical Research, and Public Health Sciences Divisions
Tip Sheet: New findings on immune response to COVID-19, new research from San Antonio Breast Cancer Symposium — and Fred Hutch expert predictions for 2022
Summaries of recent Fred Hutch research findings and other news
Tip Sheet: Fred Hutch experts and omicron, closing gaps in indigenous health disparities, new leaders in DEI and data science — and ASH 2021
Summaries of recent Fred Hutch research findings and other news
Fred Hutch at ASH: Latest findings in CAR T-cell therapy, microbiome effects on transplantation, post-transplant COVID-19 — and single-cell genomics for residual disease
The 63rd American Society of Hematology Annual Meeting and Exposition will take place virtually and in person Dec. 11–14 in Atlanta, Georgia
Tip Sheet: How to diversify vaccine clinical trials, 30 years of science education, Trevor Noah talks to Hutch scientists — and more
Summaries of recent Fred Hutch research findings and other news
Tip Sheet: New MacArthur ‘genius,’ returning to school during COVID-19 and the science of race and racism
Summaries of recent Fred Hutch research findings and other news
Distinct yet complementary T cell subsets in the human cervix
From the Zhu and Corey Lab, Vaccine and Infectious Disease Division